-

US Supreme Court rules in favor of Monsanto in the Durnell case

LEVERKUSEN, Germany--(BUSINESS WIRE)--The U.S. Supreme Court decision is good for science, farmers, and industries that depend on regulatory clarity for innovation. It should help significantly contain the Roundup™ litigation after nearly a decade of legal battles. The ruling should result in the dismissal of current warning-based claims and bar future failure-to-warn claims.

Monsanto will continue to pursue final approval of the class settlement and other elements of its multi-pronged strategy to contain the Roundup™ litigation.

The company is still reviewing the U.S. Supreme Court’s ruling and will provide a more comprehensive statement shortly.

pb (2026-0106E)

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Bayer AG is a holding company with operating subsidiaries worldwide. References to “Bayer” or “the company” herein may refer to one or more subsidiaries as context requires.

Contacts

Contact for media inquiries:
Brian Leake, phone +1 314.370.3285
Email: brian.leake@bayer.com

Philipp Blank, phone +49 214 30-20499
Email: philipp.blank@bayer.com

Contact for investor inquiries:
Bayer Investor Relations Team, phone +49 214 30-72704
Email: ir@bayer.com
www.bayer.com/en/investors/ir-team

Find more information at www.bayer.com.

Bayer AG


Release Versions

Contacts

Contact for media inquiries:
Brian Leake, phone +1 314.370.3285
Email: brian.leake@bayer.com

Philipp Blank, phone +49 214 30-20499
Email: philipp.blank@bayer.com

Contact for investor inquiries:
Bayer Investor Relations Team, phone +49 214 30-72704
Email: ir@bayer.com
www.bayer.com/en/investors/ir-team

Find more information at www.bayer.com.

More News From Bayer AG

Monsanto wins landmark Roundup™ case at U.S. Supreme Court

LEVERKUSEN, Germany--(BUSINESS WIRE)--The U.S. Supreme Court issued a 7:2 landmark ruling in the Durnell Roundup™ case on Thursday, affirming that the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) expressly preempts state-law-based failure-to-warn claims when the U.S. Environmental Protection Agency (EPA) has made a definitive determination on product safety. This decision, which reflects strong support across the ideological spectrum of the Court, helps to bring significant conta...

Bayer and Iambic Collaborate to Advance Drug Discovery with AI

BERLIN & SAN DIEGO--(BUSINESS WIRE)--Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic’s AI-driven platform. The collaboration is focused on small molecule discovery. The collaboration will leverage Iambic’s AI-driven drug discovery platform, including its flagship AI technologies, Enchant & Neu...

Federal Judge Remands Monsanto Class Settlement Case Back to MO State Court

LEVERKUSEN, Germany & ST. LOUIS--(BUSINESS WIRE)--Today, Judge Henry E. Autrey, a federal district court judge in the Eastern District of Missouri, today issued a ruling remanding the class settlement case, King v Monsanto, back to Missouri State Court. Monsanto released the following statement in response to the Court’s decision. “This decision returns jurisdiction over the class settlement to Missouri Circuit Court where the vast majority of pending claims in the Roundup litigation have been...
Back to Newsroom